Kidney Week

Oral Abstract Session

Late-Breaking Research Orals - 1

November 06, 2025 | 04:30 PM - 06:00 PM

Location: Grand Ballroom C, Convention Center

Session Description

Late-Breaking Research Orals - 1

Note: Continuing education credits are not being offered for this session.

Learning Pathway(s)

• Other

Moderators

• Eugene P. Rhee, MD, FASN
• Jodi M. Smith, MD, MPH

Presentations

• POINTER: A Phase 2b, Randomized, Placebo-Controlled, Double-Blind Dose-Finding Clinical Study of RMC-035 in Participants at High Risk for Kidney Injury Following Cardiac Surgery
  04:30 PM - 04:42 PM
  
  • Jay L. Koyner, MD, FASN

POINTER: A Phase 2b, Randomized, Placebo-Controlled, Double-Blind Dose-Finding Clinical Study of RMC-035 in Participants at High Risk for Kidney Injury Following Cardiac Surgery

November 06, 2025 | 04:30 PM - 04:42 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Albuminuria Change as a Surrogate End Point for Kidney Failure: An Updated Meta-Analysis of Randomised Controlled Trials
  04:42 PM - 04:54 PM
  
  • Hiddo Jan L. Heerspink, PhD

Albuminuria Change as a Surrogate End Point for Kidney Failure: An Updated Meta-Analysis of Randomised Controlled Trials

November 06, 2025 | 04:42 PM - 04:54 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Clinical Decision Support Tool to Enhance Angiotensin-Converting Enzyme Inhibitor (ACEI)/Angiotensin Receptor Blocker (ARB) Use in Patients with CKD
  04:54 PM - 05:06 PM
  
  • Sankar D. Navaneethan, MD, MS, MPH, FASN

Clinical Decision Support Tool to Enhance Angiotensin-Converting Enzyme Inhibitor (ACEI)/Angiotensin Receptor Blocker (ARB) Use in Patients with CKD

November 06, 2025 | 04:54 PM - 05:06 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Learning Health System Intervention to Increase SGLT2 Inhibitor Use
  05:06 PM - 05:18 PM
  
  • Areef Ishani, MD, MS

Learning Health System Intervention to Increase SGLT2 Inhibitor Use

November 06, 2025 | 05:06 PM - 05:18 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Extended In-Center Nocturnal vs. Conventional Daytime Dialysis: The NightLife Trial
  05:18 PM - 05:30 PM
  
  • James Burton, MBChB, PhD, FASN

Extended In-Center Nocturnal vs. Conventional Daytime Dialysis: The NightLife Trial

November 06, 2025 | 05:18 PM - 05:30 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Efficacy and Safety of Tegoprubart for the Prevention of Rejection in Kidney Transplantation: Results from the Phase 2 BESTOW Trial
  05:30 PM - 05:42 PM
  
  • Andrew B. Adams, MD, PhD

Efficacy and Safety of Tegoprubart for the Prevention of Rejection in Kidney Transplantation: Results from the Phase 2 BESTOW Trial

November 06, 2025 | 05:30 PM - 05:42 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Safety and Efficacy of B Cell Maturation Antigen (BCMA)/CD70-Targeted Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Pediatric Patients with Multidrug-Resistant, Steroid-Resistant Nephrotic Syndrome
  05:42 PM - 05:54 PM
  
  • Hanyan Meng

Safety and Efficacy of B Cell Maturation Antigen (BCMA)/CD70-Targeted Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Pediatric Patients with Multidrug-Resistant, Steroid-Resistant Nephrotic Syndrome

November 06, 2025 | 05:42 PM - 05:54 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.